State Of Wisconsin Investment Board Concert Pharmaceuticals, Inc. Transaction History

State Of Wisconsin Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $178,848 - $480,976	-36,800 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$9.48 - $12.84 $43,608 - $59,064	-4,600 Reduced 11.11%	36,800 $465,000
Q1 2020 May 06, 2020	BUY	$5.98 - $13.09 $54,418 - $119,119	9,100 Added 28.17%	41,400 $366,000
Q3 2019 Nov 12, 2019	BUY	$5.88 - $12.35 $18,816 - $39,520	3,200 Added 11.0%	32,300 $190,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $5,664 - $7,871	600 Added 2.11%	29,100 $349,000
Q1 2019 May 13, 2019	BUY	$12.07 - $17.54 $78,455 - $114,010	6,500 Added 29.55%	28,500 $344,000
Q4 2018 Feb 11, 2019	BUY	$11.25 - $16.17 $101,250 - $145,530	9,000 Added 69.23%	22,000 $276,000
Q3 2017 Nov 01, 2017	BUY	$13.91 - $15.31 $180,830 - $199,030	13,000	13,000 $192,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.